= Solution
For the electronic-record <observational study>, three strengths are:
* The large dataset improves precision of the estimated <statistical association> and allows detection of associations too small for a modest study.
* Adjusting for age, sex, and ancestry addresses specified measured sources of <confounding>.
* Routinely collected <hypercalcaemia> and <migraine> diagnoses give evidence from clinical practice, rather than depending solely on recalled <calcium intake>.
Three weaknesses are:
* Residual <confounding> remains possible: for example, other diseases, medicines, or health behaviours may affect both <serum calcium> and <migraine>.
* Co-occurrence does not establish temporal order, leaving <reverse causality> possible. <Migraine>, its management, or the decision to investigate it may alter recorded <serum calcium>.
* <Selection bias> and diagnostic misclassification can arise because patients enter health records and receive testing nonrandomly. Moreover, <hypercalcaemia> is not a direct measure of dietary <calcium intake>, limiting the claimed intervention's interpretation.
For <two-sample Mendelian randomization>, three strengths are:
* <Genetic variants> are inherited before adult <migraine> develops, making ordinary disease-to-genotype <reverse causality> implausible.
* Under <instrumental-variable independence>, genetic assignment reduces the environmental <confounding> that undermines a conventional <observational study>.
* The large outcome sample and combined <genetic risk score> improve precision, while concordant <weighted-median Mendelian randomization estimator> and <MR-Egger regression> results offer checks under different assumptions about <horizontal pleiotropy>.
Three weaknesses are:
* <Horizontal pleiotropy> can violate the <exclusion restriction>, while <population stratification> or inherited family effects can violate <instrumental-variable independence>. In the supplied figure, one variant has a much larger <serum calcium> association than the others, motivating a check for dependence on that single variant.
* The score explains only 1.25% of <serum calcium> <variance>, so instrument strength must be assessed rather than assumed. Different populations in the two samples can also undermine transport of genetic associations. A small variance fraction is not itself proof of a <weak instrument> in a large sample.
* A lifelong genetically influenced shift in <serum calcium> is not equivalent to changing dietary <calcium intake>. The robustness methods also need assumptions: the <weighted-median Mendelian randomization estimator> needs more than half of the weight from valid instruments, and <MR-Egger regression> needs the <InSIDE assumption>. The nonsignificant <MR-Egger regression> intercept is compatible with zero average directional <horizontal pleiotropy>, but with eight variants it cannot prove all instruments valid.
Thus \b[the agreement supports the hypothesis, but does not establish the effect of a dietary intervention].
Back to article page
